Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience.
about
MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancerAn updated overview of HPV-associated head and neck carcinomasCoexistence between renal cell cancer and Hodgkin's lymphoma: a rare coincidence.Association of p53 codon 72 polymorphism with risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck.FAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck.Chemoprevention of oral cancer by lyophilized strawberries.Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancerEfficacy of Varunadi Ghritha (polyherbal compound) in treated head and neck cancer cases as a biological response modifierAnatomic sites at elevated risk of second primary cancer after an index head and neck cancer.Oral hybrid verrucous carcinoma: a clinical studyInduction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial.Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1-2 glottic cancerThe influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines.Identification of second malignancies on effusions and fine-needle aspirates using a panel of monoclonal antibodies.High prevalence of discordant human papillomavirus and p16 oropharyngeal squamous cell carcinomas in an African American cohort.Screening for oesophageal neoplasia in patients with head and neck cancerRisk of Esophageal Cancer Following Percutaneous Endoscopic Gastrostomy in Head and Neck Cancer Patients: A Nationwide Population-Based Cohort Study in Taiwan.Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating riskPrevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results DatabaseOutcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo ClinicA Retrospective Evaluation of Clinical Profile of Second Primary Head and Neck Cancer.Alcohol and tobacco use prediagnosis and postdiagnosis, and survival in a cohort of patients with early stage cancers of the oral cavity, pharynx, and larynx.A head and neck cancer intervention for use in survivorship clinics: a protocol for a feasibility study.Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma.Novel Molecular Targets for Chemoprevention in Malignancies of the Head and Neck.Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).Reirradiation of head and neck cancer in the era of intensity-modulated radiotherapy: patient selection, practical aspects, and current evidence.Spindle cell carcinoma of the tongue combined with double primary cancer of the thyroid gland: a case report.Radiation-Induced Malignancies Making Radiotherapy a "Two-Edged Sword": A Review of Literature.p53 status of head and neck cancer: relation to biological characteristics and outcome of radiotherapy.Second malignant tumours in head and neck cancer.Results of Treatment of Squamous Cell Carcinoma of Maxillary Sinus: A 26-Year Experience.Risk interrelationship among multiple primary tumors: A case report and review of literature.Four synchronous cancers in a patient with tongue pain as the only symptom.Metachronous second primary malignancy in head and neck cancer patients: is five years of follow-up sufficient?
P2860
Q24629078-A0BD1F21-CA1D-4A7E-99F3-97C2858CCF45Q27014019-6E0DEE78-C739-483E-AADD-4327FC917B8FQ33237092-9D5BAC18-FA84-44B4-9DBE-89FD3936D385Q33828852-E3082F01-9E5E-4D51-A79B-1322115666C3Q33903227-3FEDB60B-7735-46D4-98AD-7F774F530D7BQ33915646-859C97CD-403F-424C-A26E-0FB89B2CFF41Q34667840-E5A142E4-004A-49E1-9AF7-DD8205A3E0FFQ34786331-2EE61F7F-7726-4012-8564-06183F824AB3Q34892580-DFDC4EFC-D255-4EF9-8A87-63CDFFD55422Q35162830-D9F11754-3113-4B35-BB18-DD4AB08349CCQ35169306-0C0EB1B4-176B-4902-9A9D-CE379AA90294Q35839993-59B96807-CBDC-4561-B988-2C174A37AD45Q36069729-0711733A-B811-4D22-B5A6-297EBDF3E67BQ36116063-F7EF1F14-6B18-45BF-B127-B4748748FB5EQ36276044-CDE428FE-4150-49A7-A5CF-8E31A44EEBF3Q36643673-5EBAE192-A84E-481D-9BA1-AA2EEB5CCA57Q36664061-AC6A7951-B2AB-4870-97C9-3C13E0FB57A2Q36736612-75E84394-742A-4CE4-91C2-4A03B806E6D7Q36757760-B5BF35B1-0C79-4277-93C7-86B9B7EFA9EAQ36783381-FC9700B8-147D-414F-9DE9-8BB9D67D779EQ37435811-1E579512-8F9E-437F-9087-08389AD0F900Q37461626-18B79182-347A-4AAE-BCEF-EA2DD61D6725Q37497976-BC92AF91-00E4-482C-9DAB-C08ED9BB8A9EQ37609476-E693E5CF-30B6-42E3-99E3-9D02EF00F4FFQ38635035-C3D0302D-7DEE-4367-95FD-2CDE5828E38CQ38645642-A44ABB7F-F786-45EE-8E21-1C423F46A39AQ38844023-E3B96B4E-1E27-487E-BB3A-5E85F46C1400Q41002273-826F09EE-A85A-4DA2-8006-4B5B07CFFDBFQ41835022-FC71B141-1697-4A39-B057-64234D1E2EB6Q42590686-E6B33BAB-602A-437A-8C9F-63B7D902850BQ43165882-B23E66DA-1515-48AB-AEB1-299092055D8BQ46725624-CEB45F1F-5FE3-436A-ABC8-733BB33C4D6AQ52593861-B7729F62-A4BB-41F1-9938-071880BDAF7DQ52983143-B082D5B9-B290-40E1-BCE9-269C63CF7E01Q58595829-ECC95C04-0F1C-4C63-B84B-13C86CE0617E
P2860
Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience.
description
1989 nî lūn-bûn
@nan
1989 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
name
Second malignancies in patient ...... based on the RTOG experience.
@ast
Second malignancies in patient ...... based on the RTOG experience.
@en
Second malignancies in patient ...... based on the RTOG experience.
@nl
type
label
Second malignancies in patient ...... based on the RTOG experience.
@ast
Second malignancies in patient ...... based on the RTOG experience.
@en
Second malignancies in patient ...... based on the RTOG experience.
@nl
prefLabel
Second malignancies in patient ...... based on the RTOG experience.
@ast
Second malignancies in patient ...... based on the RTOG experience.
@en
Second malignancies in patient ...... based on the RTOG experience.
@nl
P2093
P1476
Second malignancies in patient ...... based on the RTOG experience.
@en
P2093
Laramore GE
Marcial VA
Tupchong L
P304
P407
P577
1989-09-01T00:00:00Z